Fertility rate, total (births per woman) in China was reported at 0.999 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. China - Fertility rate, total (births per woman) - actual values, historical data, forecasts and projections were sourced from the World Bank on August of 2025.

Historical dataset showing China fertility rate by year from 1950 to 2025.

Historical dataset showing China birth rate by year from 1950 to 2025.

Adolescent fertility rate (births per 1,000 women ages 15-19) in China was reported at 5.227 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. China - Adolescent fertility rate (births per 1,000 women ages 15-19) - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

Birth rate, crude (per 1,000 people) in China was reported at 6.39 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. China - Birth rate, crude - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

The fertility rate of a country is the average number of children that women from that country will have throughout their reproductive years. In 1930, China's fertility rate was 5.5 children per woman, and this number then dropped to just under five over the next fifteen years, as China experienced a civil war and the Second World War. The fertility rate rose rather quickly after this to over 6.1 in 1955, before dropping again in the late 1950s, as Chairman Mao's 'Great Leap Forward' failed to industrialize the nation, and resulted in widespread famine that killed an estimated 45 million people. In the decade following this, China's fertility rate reached it's highest level in 1970, before the implementation of the two-child policy in the 1970s, and the one-child policy** in the 1980s, which radically changed the population structure. The fertility rate fell to an all time low in the early 2000s, where it was just 1.6 children per woman. However this number has increased to 1.7 today, and the two-child policy was reintroduced in 2016, replacing the one-child policy that had been effective for over 36 years.

According to latest figures, the Chinese population decreased by 1.39 million to around 1.408 billion people in 2024. After decades of rapid growth, China arrived at the turning point of its demographic development in 2022, which was earlier than expected. The annual population decrease is estimated to remain at moderate levels until around 2030 but to accelerate thereafter. Population development in China China had for a long time been the country with the largest population worldwide, but according to UN estimates, it has been overtaken by India in 2023. As the population in India is still growing, the country is very likely to remain being home of the largest population on earth in the near future. Due to several mechanisms put into place by the Chinese government as well as changing circumstances in the working and social environment of the Chinese people, population growth has subsided over the past decades, displaying an annual population growth rate of -0.1 percent in 2024. Nevertheless, compared to the world population in total, China held a share of about 17 percent of the overall global population in 2024. China's aging population In terms of demographic developments, the birth control efforts of the Chinese government had considerable effects on the demographic pyramid in China. Upon closer examination of the age distribution, a clear trend of an aging population becomes visible. In order to curb the negative effects of an aging population, the Chinese government abolished the one-child policy in 2015, which had been in effect since 1979, and introduced a three-child policy in May 2021. However, many Chinese parents nowadays are reluctant to have a second or third child, as is the case in most of the developed countries in the world. The number of births in China varied in the years following the abolishment of the one-child policy, but did not increase considerably. Among the reasons most prominent for parents not having more children are the rising living costs and costs for child care, growing work pressure, a growing trend towards self-realization and individualism, and changing social behaviors.

In China Fertility Market is projected to grow from USD 28.4 billion in 2025 to USD 51.9 billion by 2031, at a CAGR of 10.5%

The China Fertility Services Market is segmented into the following products:Assisted reproductive technology (ART)Infertility drugsFertility preservation treatmentsGenetic testingOther fertility servicesThe ART segment is the largest segment, accounting for over 60% of the market share. The other fertility services segment is the fastest growing segment, with a CAGR of over 10%.

Life expectancy at birth, total (years) in China was reported at 77.95 years in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. China - Life expectancy at birth, total (years) - actual values, historical data, forecasts and projections were sourced from the World Bank on August of 2025.

Comprehensive dataset of 0 Fertility clinics in China as of July, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

DATASET: Alpha version 2010, 2012, 2015, 2020, 2025, 2030, and 2035 estimates of numbers of live births per grid square, with national totals adjusted to match UN national estimates on numbers of live births (http://esa.un.org/wpp/). REGION: Asia SPATIAL RESOLUTION: 0.000833333 decimal degrees (approx 100m at the equator) PROJECTION: Geographic, WGS84 UNITS: Estimated births per grid square MAPPING APPROACH: Tatem AJ, Campbell J, Guerra-Arias M, de Bernis L, Moran A, Matthews Z, 2014, Mapping for maternal and newborn health: the distributions of women of childbearing age, pregnancies and births, International Journal of Health Geographics, 13:2 FORMAT: Geotiff (zipped using 7-zip (open access tool): www.7-zip.org) FILENAMES: Example - AZE2010adjustedBirths.tif = Azerbaijan (AZE) births count map for 2010 adjusted to match UN national estimates on numbers of live births. DATE OF PRODUCTION: May 2014

Life expectancy at birth, male (years) in China was reported at 75.2 years in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. China - Life expectancy at birth, male (years) - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

Snapshot img

Fertility Supplements Market Size 2025-2029

The fertility supplements market size is forecast to increase by USD 843.8 million, at a CAGR of 7.3% between 2024 and 2029. Availability of online purchase will drive the fertility supplements market.

Major Market Trends & Insights

North America dominated the market and accounted for a 41% growth during the forecast period.
By End-user - Women segment was valued at USD 910.80 million in 2023
By Form Factor - Capsules segment accounted for the largest market revenue share in 2023

Market Size & Forecast

Market Opportunities: USD 70.99 million
Market Future Opportunities: USD 843.80 million 
CAGR : 7.3%
North America: Largest market in 2023

Market Summary

The market represents a significant and continually evolving sector within the health and wellness industry. Core technologies and applications, such as herbal extracts, vitamins, and minerals, play a crucial role in the development and production of these supplements. The market is segmented into various product categories, including prenatal vitamins, men's fertility supplements, and herbal supplements. Key companies, including Herbalife Nutrition, Nutraceutical Corporation, and Swanson Health Products, dominate the market with their extensive product offerings and strong market presence. The market's growth is driven by factors such as increasing cases of infertility, an aging population seeking to maintain reproductive health, and the availability of online purchasing options. However, challenges such as the risk associated with unregulated supplements and potential side effects pose significant hurdles for market growth. Regulations, particularly from the Food and Drug Administration (FDA), play a critical role in ensuring the safety and efficacy of fertility supplements. According to recent studies, The market is expected to witness a steady growth trajectory in the forecast period, with a significant increase in adoption rates. For instance, the prenatal vitamins segment is projected to account for over 50% of the market share due to their importance in supporting maternal health and fetal development. Related markets such as the dietary supplements and pharmaceuticals industries also significantly influence the market. Stay tuned for more insights and updates on this dynamic market.

What will be the Size of the Fertility Supplements Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the Fertility Supplements Market Segmented and what are the key trends of market segmentation?

The fertility supplements industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments. End-userWomenMenForm FactorCapsulesTabletsGummiesPowdersOthersProduct TypeHerbal supplementsVitamin-basedMineral-basedAmino acids and antioxidantsProbioticsGeographyNorth AmericaUSCanadaEuropeFranceGermanyItalySpainUKAPACChinaIndiaJapanRest of World (ROW)

By End-user Insights

The women segment is estimated to witness significant growth during the forecast period.

The market is experiencing significant growth, driven by the increasing prevalence of infertility issues and the expanding demand for natural and sustainable solutions. Approximately 17.5% of individuals of reproductive age worldwide have experienced infertility at some point in their lives, according to the World Health Organization's 2023 report. Disorders such as polycystic ovarian syndrome (PCOS), endometriosis, premature ovarian failure, and pelvic inflammatory disease are just a few of the systemic and gynecological conditions that can negatively impact the female reproductive system. To address these challenges, the market for fertility supplements is evolving rapidly. Nitrogen fixation bacteria and root growth stimulants are increasingly being used to improve soil health and nutrient availability, enhancing crop stress tolerance and promoting sustainable agriculture. Microbial inoculants and plant hormone modulators are also gaining popularity for their role in nutrient deficiency diagnosis and soil testing methods, as well as for drought stress mitigation and water use efficiency. Moreover, fertilizer blend formulations, humic acid fertilizers, and foliar fertilizer applications are being employed to optimize nutrient uptake efficiency and improve fruit quality. Precision fertilization and grain quality enhancement are also key trends, as growers seek to minimize waste and maximize yields. Phosphorus solubilizing fungi, plant growth regulators, and soil nutrient cycling are also essential components of this evolving market. Looking ahead, industry experts anticipate continued growth, with expectations of a 21.3% increase in market siz

While the BRICS countries are grouped together in terms of economic development, demographic progress varies across these five countries. In 2019, India and South Africa were the only BRICS countries with a fertility rate above replacement level (2.1 births per woman). Fertility rates since 2000 show that fertility in China and Russia has either fluctuated or remained fairly steady, as these two countries are at a later stage of the demographic transition than the other three, while Brazil has reached this stage more recently. Fertility rates in India are following a similar trend to Brazil, while South Africa's rate is progressing at a much slower pace. Demographic development is inextricably linked with economic growth; for example, as fertility rates drop, female participation in the workforce increases, as does the average age, which then leads to higher productivity and a more profitable domestic market.

Sex ratio at birth (male births per female births) in China was reported at 1.108 in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. China - Sex ratio at birth (male births per female births) - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

The China fertilizers market is expected to grow from XX million in 2025 to XX million by 2033, at a CAGR of 6.50% during the forecast period. The market is driven by the increasing demand for fertilizers from the agricultural sector, which is a major contributor to the country's economy. The rising population and urbanization in China have led to an increase in the demand for food, which in turn has boosted the demand for fertilizers. The market is also supported by the government's policies, which promote the use of fertilizers to improve crop yields and soil fertility. The government provides subsidies to farmers for the purchase of fertilizers, and it also invests in research and development to improve fertilizer production and distribution. The increasing use of precision agriculture techniques, which allow farmers to apply fertilizers more efficiently, is also expected to drive the growth of the market. China Fertilizer Market report provides an in-depth analysis of the market and its dynamics, including segmentation, market size, forecasts, and competitive analysis. Our report discusses the influence of COVID-19 and the subsequent post-pandemic recovery, exploring the market's long-term growth prospects. Recent developments include: January 2023: ICL has entered into a strategic partnership agreement with General Mills, in which it will be the supplier of strategic specialty phosphate solutions to General Mills. The long-term agreement will also focus on international expansion.May 2022: ICL launched three new NPK formulations of Solinure, a product with increased trace elements to optimize yields.May 2022: ICL signed an agreement with customers in India and China to supply 600,000 and 700,000 metric tons of potash, respectively, in 2022 at USD 590 per ton.. Key drivers for this market are: Shortage of Skilled Labor, Government Support to Enhance Farm Mechanization. Potential restraints include: Heavy Initial Procurement Cost and High Expenditure on Maintenance. Notable trends are: OTHER KEY INDUSTRY TRENDS COVERED IN THE REPORT.

The market size was valued at USD 1.5 billion in 2021 and will be 2.2 billion by 2030 with a CAGR of 8.2% during the forecast period. Factors Affecting Infertility TreatmentMarket Growth

Government spending on healthcare facilities

The federal government's increased support will likely accelerate market expansion. Additionally, the development and expansion of the healthcare sector, pushed by both public and private sectors, particularly in developing nations, will provide attractive potential for market expansion. High returns on investments, which are guaranteed by research efforts, would also benefit the market. Additionally, a rise in personal disposable income, an increase in the number of fertility clinics around the world, an increase in investment in the development of cutting-edge medical products and devices, and the growth of emerging Infertility markets will contribute to the market's positive rate of expansion.

Increasing frequency of the infertility

The demand for infertility is growing in male and females that result in an increasing demand for sterile treatment, Delayed parenthood, sexual transmission disease, aging, lifestyles are the factors that impact infertility. Therefore, there is faster growth in this field.

The Restraining Factor of Infertility Treatment:

High cost associated with treatment 

It is anticipated that barriers to market expansion will include high costs associated with research and development capabilities, a lack of adequate infrastructure, and increased complexity and concerns surrounding assisted reproductive technology (ART). In addition, during the forecast period of 2022–2029, the market is anticipated to face challenges from an unfavourable reimbursement scenario, a lack of technology penetration in developing economies, high costs associated with assisted reproductive technology (ART) procedures, and an inadequate infrastructure in low- and middle-income nations. This hampers the infertility market.

Opportunities on Infertility Treatment

Developing economies in APAC and RoW:

Market participants for infertility treatments can anticipate finding significant growth opportunities in developing nations like China, India, Brazil, and Mexico. The Asia market is different from other growing nations, due to greater focus on infrastructure upgrades in the healthcare sector. For a variety of reasons, the medical tourism industry is also booming in developing countries. The quality of the healthcare facilities in Asia is very excellent. The medical procedures are reasonably priced, and many of the physicians and surgeons were educated at renowned universities in the US and Europe. Emerging markets including India, China, Singapore, Thailand, Brazil, and Malaysia offer promising opportunities for the growth of the global market.

Impact of the COVID-19 pandemic on the Infertility Treatment Market:

The market has been negatively impacted by COVID-19. The market growth rate was slowed down as attention was diverted from non-essential healthcare services to meet COVID-19 patient expectations. Guidelines were established to prevent front-line hospital and public employees from contracting the COVID-19 virus. Due to the cancellation of in vitro fertilisation procedures, 90% decrease in the number of people having in vitro fertilisation cycles was seen during this pandemic phase. The infertility market growth rate was hampered as a result of everything. Introduction of Infertility Treatment

Infertility means a woman is not able to conceive after trying for more than a year. Infertility occurs when a woman can become pregnant but tends to experience miscarriages. Infertility treatment largely depends on the underlying cause and objectives. A treatment will be chosen for you based on your age, length of infertility treatment, and personal preferences. Sometimes only one person needs treatment, and other times both spouses must participate. In most circumstances, infertile individuals and couples have a high possibility of getting pregnant. The use of assisted reproductive technology (ART), surgery, or medication can be beneficial.

Comprehensive dataset of 1 Pregnancy care centers in Guangdong Province, China as of July, 2025. Includes verified contact information (email, phone), geocoded addresses, customer ratings, reviews, business categories, and operational details. Perfect for market research, lead generation, competitive analysis, and business intelligence. Download a complimentary sample to evaluate data quality and completeness.

The fertility pregnancy rapid test kits market is expected to witness stable growth, with global sales projected to reach USD 1.60 billion in 2025. This reflects an increase from an estimated USD 1.5 billion in 2024. By 2035, the market is forecasted to expand to USD 2.49 billion, registering a CAGR of 4.5%.

Attributes	Key Insights
Historical Size, 2024	USD 1.5 billion
Estimated Size, 2025	USD 1.60 billion
Projected Size, 2035	USD 2.49 billion
Value-based CAGR (2025 to 2035)	4.5%

Semi Annual Market Update

Particular	Value CAGR
H1	5.2% (2024 to 2034)
H2	4.9% (2024 to 2034)
H1	4.5% (2025 to 2035)
H2	4.0% (2025 to 2035)

Analyzing Fertility Pregnancy Rapid Test Kits Market Market by Top Investment Segments

By Product	Value Share (2025)
Pregnancy Rapid Tests	57.0%

By Test Type	Value Share (2025)
hCG Urine	45.3%

Country-wise Insights

Countries	Value CAGR (2025 to 2035)
United States	3.8%
Germany	4.8%
Italy	3.6%
UK	4.5%
China	6.9%
India	6.6%
Japan	5.0%